HIF1A and hepatocellular carcinoma: HIF-1α levels were significantly higher in cirrhotics (0.43 ng/mL [0.32–0.54]) than in HCC patients, both before (0.23 ng/mL [0.12–0.49]; p = 0.02) and after DEB-TACE (0.23 ng/mL [0.12–0.46]; p = 0.009).